miltefosine has been researched along with Psoriasis in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, PJ | 1 |
| van der Meide, WF | 1 |
| Godfried, MH | 1 |
| Schallig, HD | 1 |
| Dinant, HJ | 1 |
| Faber, WR | 1 |
1 other study available for miltefosine and Psoriasis
| Article | Year |
|---|---|
Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBA.
Topics: Administration, Oral; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Viscera | 2006 |